Extracellular Matrix–related six-lncRNA signature as a novel prognostic biomarker for bladder cancer

L Qing, P Gu, M Liu, J Shen, X Liu, R Guang… - OncoTargets and …, 2020 - Taylor & Francis
Introduction Bladder cancer (BC) is the fourth-commones cancer and the sixth-leading
cause of cancer-related death among men. However, a lack of reliable biomarkers remains …

Long non-coding RNA in lung cancer

Z Chen, T Lei, X Chen, J Gu, J Huang, B Lu, Z Wang - Clinica chimica acta, 2020 - Elsevier
Lung cancer is the leading cause of cancer-related death worldwide. Owing to the difficulty
in early diagnosis and the lack of effective treatment strategies, the 5-year survival rates for …

Long noncoding RNAs: new players in prostate cancer

W Cheng, Z Zhang, J Wang - Cancer letters, 2013 - Elsevier
Prostate cancer is the most common type of cancer and frequent cause of cancer-related
mortality in men worldwide. Despite its commonness, the underlying molecular mechanism …

Long noncoding RNAs in cancer: from discovery to therapeutic targets

R Choudhari, MJ Sedano, AL Harrison… - Advances in clinical …, 2020 - Elsevier
Long noncoding RNAs (lncRNAs) have recently gained considerable attention as key
players in biological regulation; however, the mechanisms by which lncRNAs govern …

Decoding long non-coding RNAs: Friends and foes in cancer development

H Song, J Adu-Amankwaah… - International …, 2024 - spandidos-publications.com
Cancer remains a formidable adversary, challenging medical advancements with its dismal
prognosis, low cure rates and high mortality rates. Within this intricate landscape, long non …

Integrative analysis of the lncRNA-associated ceRNA network reveals lncRNAs as potential prognostic biomarkers in human muscle-invasive bladder cancer

L Lyu, W Xiang, JY Zhu, T Huang, JD Yuan… - Cancer management …, 2019 - Taylor & Francis
Background Long noncoding RNAs (lncRNAs) play important roles in competing
endogenous RNA (ceRNA) networks involved in the development and progression of …

Potential of long non‐coding RNAs in cancer patients: from biomarkers to therapeutic targets

S Chandra Gupta… - International journal of …, 2017 - Wiley Online Library
Because of high specificity and easy detection in the tissues, serum, plasma, urine and
saliva, interest in exploring the potential of long non‐coding RNAs (lncRNAs) in cancer …

Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis

C Jiang, X Li, H Zhao, H Liu - Molecular cancer, 2016 - Springer
Long non-coding RNAs (lncRNAs) play important roles in malignant neoplasia. Indeed,
many hallmarks of cancer define that the malignant phenotype of tumor cells are controlled …

Development of a novel six‐long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma

X Gao, S Zhang, Y Chen, X Wen… - Journal of cellular …, 2019 - Wiley Online Library
Bladder urothelial carcinoma is a malignant tumor with a high incidence in the uropoietic
system. Considerable studies have shown that long noncoding RNA (lncRNA) plays an …

Molecular and cellular functions of long non-coding RNAs in prostate and breast cancer

YS Zhu, J Zhu - Advances in clinical chemistry, 2022 - Elsevier
Long noncoding RNAs (lncRNAs) are defined as noncoding RNA transcripts with a length
greater than 200 nucleotides. Research over the last decade has made great strides in our …